<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04996940</url>
  </required_header>
  <id_info>
    <org_study_id>145421a</org_study_id>
    <nct_id>NCT04996940</nct_id>
  </id_info>
  <brief_title>Comparative Acceptability of Tobacco and Menthol Flavored E-cigarettes</brief_title>
  <official_title>Comparative Acceptability of Tobacco and Menthol Flavored E-cigarettes Among Menthol Cigarette Smokers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Kansas Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Kansas Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is a randomized crossover trial. Current menthol smokers will complete a session&#xD;
      with each flavor of an electronic cigarette: menthol and tobacco. The objective of this&#xD;
      survey is to assess for flavor preference.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participants who report typically smoking menthol cigarettes will be invited to complete a&#xD;
      session. Participants will undergo overnight tobacco/nicotine abstinence before the visit&#xD;
      (eCO&lt;12ppm). Participants will then be randomized 1:1 to e-cigarette flavor order (tobacco&#xD;
      e-cigarette, menthol e-cigarette). They will complete a 30-minute ad libitum session with the&#xD;
      first product, based on randomization, followed by a 1.5 hour standard washout period,&#xD;
      followed by a 30-minute ad libitum vaping session with the second product. Throughout each&#xD;
      session, puff topography will be measured via a pressure sensor attached to the e-cigarette&#xD;
      device. Participants will complete self-report measures of smoking urges and withdrawal&#xD;
      symptoms pre- and post-vaping session. In addition, they will complete measures of subjective&#xD;
      vaping experience, perceptions of flavor, product demand, and intentions for future use.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">June 20, 2021</start_date>
  <completion_date type="Anticipated">August 15, 2021</completion_date>
  <primary_completion_date type="Anticipated">August 15, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Participants will then be randomized 1:1 to e-cigarette flavor order (tobacco e-cigarette, menthol e-cigarette). They will complete a 30-minute ad libitum session with the first product, based on randomization, followed by a 1.5 hour standard washout period, followed by a 30-minute ad libitum vaping session with the second product.</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Questionnaire Scale &quot;Intentions for Future Use&quot;</measure>
    <time_frame>during the intervention</time_frame>
    <description>Using the questionnaire scale &quot;Intentions for Future Use&quot; How much each participant intends to use the products in the future</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Questionnaire Scale &quot;Subjective Vaping Experience&quot;</measure>
    <time_frame>during the intervention</time_frame>
    <description>The participant's liking or disliking of the products based on the Questionnaire Scale &quot;Subjective Vaping Experience&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Questionnaire Scale &quot;Perceptions of flavor&quot;</measure>
    <time_frame>during the intervention</time_frame>
    <description>How much the participant likes each flavor based on the Questionnaire Scale &quot;Perceptions of flavor&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Questionnaire Scale &quot;Product demand&quot;</measure>
    <time_frame>during the intervention</time_frame>
    <description>How much the participants need to use the products based on the Questionnaire Scale &quot;Product demand&quot;</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Tobacco Use Disorder</condition>
  <arm_group>
    <arm_group_label>Tobacco then Menthol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Current menthol smokers will be randomized to session order and complete a 30 minute ad libitum session with each product (tobacco e-cigarette and menthol e-cigarette).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Menthol then tobacco</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Current menthol smokers will be randomized to session order and complete a 30 minute ad libitum session with each product (menthol e-cigarette and tobacco e-cigarette).</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>E-cigarette product</intervention_name>
    <description>Participants will then be randomized 1:1 to e-cigarette flavor order (tobacco e-cigarette, menthol e-cigarette). They will complete a 30-minute ad libitum session with each flavor, based on randomization. Throughout each session, puff topography will be measured via a pressure sensor attached to the e-cigarette device.</description>
    <arm_group_label>Menthol then tobacco</arm_group_label>
    <arm_group_label>Tobacco then Menthol</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  typically smoking menthol cigarettes&#xD;
&#xD;
          -  Non-Hispanic African American or white/Caucasian,&#xD;
&#xD;
          -  ≥21 years old, smoke 5-30 cigarettes per day,&#xD;
&#xD;
          -  daily cigarette smoker&#xD;
&#xD;
          -  smoked at current rate for at least 6 months&#xD;
&#xD;
          -  interested in trying e-cigarettes&#xD;
&#xD;
          -  not interested in or unable/unwilling to quit cigarette smoking&#xD;
&#xD;
          -  willing to complete one in-person study visits&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Interested in quitting cigarettes in the next 30 days&#xD;
&#xD;
          -  use of smoking cessation pharmacotherapy in the past 30 days&#xD;
&#xD;
          -  use of non-cigarette tobacco products in the past 30 days&#xD;
&#xD;
          -  use of e-cigarettes &gt;5x in lifetime&#xD;
&#xD;
          -  use of e-cigarettes ≥4 of the past 30 days&#xD;
&#xD;
          -  weight &lt; 110 lbs&#xD;
&#xD;
          -  uncontrolled hypertension (systolic BP ≥ 180 or diastolic BP ≥ 105)&#xD;
&#xD;
          -  pregnant, plans to become pregnant, or breastfeeding&#xD;
&#xD;
          -  live &gt;10 miles from study site (Fairway CRU)&#xD;
&#xD;
          -  current enrollment is a research study or program that aims to alter tobacco use&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Kansas Medical Center</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>66160</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 14, 2021</study_first_submitted>
  <study_first_submitted_qc>July 30, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 9, 2021</study_first_posted>
  <last_update_submitted>July 30, 2021</last_update_submitted>
  <last_update_submitted_qc>July 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>tobacco</keyword>
  <keyword>e-cigarette</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tobacco Use Disorder</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

